PCRX Latest Press Releases

-- October 12, 2026 --

Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders? PRNewswire 8:50 PM

Pacira BioSciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pacira BioSciences, Inc. - PCRX Business Wire 12:43 PM

-- October 11, 2026 --

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX) PRNewswire 12:30 PM

-- October 8, 2026 --

PCRX SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES PACIRA BIOSCIENCES, INC. PRNewswire 12:13 PM

PCRX Stock Alert: Halper Sadeh LLC is Investigating Whether Pacira BioSciences, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 8:36 AM

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies PRNewswire 7:45 AM

-- October 7, 2026 --

Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home Globe Newswire 8:00 AM

-- October 5, 2026 --

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL in the European Union and United Kingdom Globe Newswire 8:00 AM

-- September 9, 2026 --

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- August 7, 2026 --

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- August 6, 2026 --

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases Globe Newswire 8:00 AM

-- August 4, 2026 --

Pacira BioSciences Reports Second Quarter 2026 Financial Results Globe Newswire 4:01 PM

-- July 28, 2026 --

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America's Workforce Globe Newswire 8:00 AM

-- July 27, 2026 --

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process Globe Newswire 8:00 AM

-- July 22, 2026 --

Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026 Globe Newswire 8:00 AM

-- July 8, 2026 --

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- July 1, 2026 --

Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL Globe Newswire 8:00 AM

-- June 30, 2026 --

Pacira BioSciences Announces Agreement to Divest its iovera Business to Zimmer Biomet Globe Newswire 7:30 AM

-- June 9, 2026 --

Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting PRNewswire 5:54 PM

-- June 4, 2026 --

Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting PRNewswire 4:20 PM

-- June 1, 2026 --

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees PRNewswire 4:50 PM

-- May 28, 2026 --

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "FOR" All of Pacira's Director Nominees Globe Newswire 4:20 PM

DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION PRNewswire 9:19 AM

-- May 27, 2026 --

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified Nominees Globe Newswire 4:20 PM

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead Globe Newswire 9:00 AM

Pacira BioSciences Reports Real-World Study Showing EXPAREL Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes